Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
SWOG Cancer Research Network
SWOG Cancer Research Network
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center